CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 93 enrolled
Drug / intervention
Sam Ultrasonic Diathermy Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02083861
NCT02083861N/ACompleted
CompareCT.gov

ZetrOZ Wearable Ultrasound Clinical Study

ZetrOZ, Inc.·interventional·Posted Mar 11, 2014·Updated May 7, 2018

In Brief

A clinical study evaluating Sam Ultrasonic Diathermy Device for Knee Osteoarthritis. Completed, enrolled 93 participants across 1 site.

Detailed Summary

The purpose of this study is to measure the effectiveness of a wearable therapeutic ultrasound device in patients with stage I and stage II knee osteoarthritis. The ability of the device to reduce pain, increase mobility, increase range of motion and muscle strength of the affected leg, and improve quality of life in patients with knee osteoarthritis will be evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute on Minority Health and Health Disparities (NIMHD)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 11, 2014
Enrollment StartMar 1, 2014
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.3 years ago

Interventions

Sam Ultrasonic Diathermy Devicedevice

Patients apply the Sam Ultrasonic Diathermy Device daily for 4 hours of continuous therapeutic ultrasound at 3 megahertz (MHz) frequency and 0.132 Watts/cm2.